Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × belantamab mafodotin × Plasma cell × Clear all

Status

Sponsor Class

Study Type

Interventional 51 Observational 2 Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

elotuzumab 4 Bortezomib 3 selinexor 2 pomalidomide 2 carfilzomib 2 Panobinostat 2 Lenalidomide 2 Dexamethasone 2 venetoclax 1 talquetamab 1 plerixafor 1 idecabtagene vicleucel 1 fludarabine phosphate 1 daratumumab 1 ceritinib 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Tacrolimus 1 Prednisone 1 Mycophenolic Acid 1 Melphalan 1 Cytarabine 1 Crizotinib 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03763370 2024-10-15

Managed Access Program for Combination Treatment With Belantamab Mafodotin in Multiple Myeloma

GlaxoSmithKline

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡